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1 
Abstract 1 
Background:  Patients with Parkinson disease (PD) present cardiovascular autonomic 2 
dysfunction which impairs blood pressure control. However, cardiovascular responses 3 
during resistance exercise are unknown in these patients. 4 
Objective: Investigate the cardiovascular responses during resistance exercise 5 
performed with different muscle masses, in patients with PD. 6 
Design:  Two groups, repeated-measures design. 7 
Setting: Exercise Hemodynamic Laboratory, School of Physical Education and Sport, 8 
University of São Paulo. 9 
Participants: Thirteen patients with PD (4 women, 62.7±1.3 years, stages 2-3 of 10 
modified Hoehn and Yahr scale; "on" state of medication) and thirteen paired controls 11 
without PD (7 women, 66.2±2.0years) 12 
Interventions: Both groups performed, in a random order, bilateral and unilateral knee 13 
extension exercises (2 sets, 10–12 RM, 2 min of interval). 14 
Main Outcome Measurements: Systolic blood pressure (SBP) and heart rate (HR) 15 
were assessed before (pre) and during the exercises. 16 
Results: Independent of set and exercise type, SBP and HR increases were significantly 17 
lower in PD than the control group (combined values: +45±2 vs. +73±4 mmHg and 18 
+18±1 vs. +31±2 bpm, P =.003 and .007, respectively). Independently of group and set, 19 
the SBP increase was greater in the bilateral than the unilateral exercise (combined 20 
values: +63±4 vs +54±3 mmHg, P=.002), while the HR increase was similar. In 21 
addition, independently of group and exercise type, the SBP increase was higher in the 22 
2
nd 
than the 1
st
 set (combined values: +56±4 vs +61±4 mmHg, P=.04), while the HR23 
increases were similar. 24 
*3.) Blinded Manuscript (without personal identifiers)
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Conclusions: Patients with PD present attenuated increases in SBP and HR during 25 
resistance exercise in comparison with healthy subjects. These results support that 26 
resistance exercise is safe and well tolerated for patients with PD from a cardiovascular 27 
point of view supporting its recommendation for this population. 28 
Level of evidence: II 29 
  30 
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 31 
INTRODUCTION 32 
 Parkinson´s disease (PD) is a neurodegenerative progressive disease of the 33 
central nervous system mainly characterized by motor dysfunction symptoms, such as 34 
rigidity, resting tremor, bradykinesia, akinesia and postural instability[1]. In addition, 35 
patients usually present with autonomic dysfunction, including cardiovascular 36 
dysfunction[2] that often occurs in the latter stages of the disease but sometimes 37 
earlier[3]. The cardiovascular autonomic dysfunction in PD is mainly characterized by 38 
reductions in sympathetic and parasympathetic activities, as well as in baroreflex 39 
sensitivity[4]; which impairs blood pressure (BP) control[5]. 40 
 Physical training is highly recommended to attenuate motor dysfunction and 41 
physical deconditioning in patients with PD[6]. In addition, it improves cognitive 42 
function, drug efficacy and sleep pattern, as well as prevents depression and 43 
cardiovascular complications[6]. In particular, resistance training is especially important 44 
to improve muscle strength, gait speed and gait initiation in these patients, which 45 
decreases motor disability, increasing the ability to perform activities of daily living and 46 
improving quality of life [7,8]. Our group has also demonstrated that resistance training 47 
improves cardiovascular autonomic dysfunction in PD[7]. However, cardiovascular 48 
responses during resistance exercise are largely unknown in patients with PD, requiring 49 
further investigation, since abnormal responses may acutely increase cardiovascular 50 
risk[8] and/or increase the risk of orthostatic intolerance symptoms[9]. 51 
In healthy individuals, heart rate (HR) and systolic BP (SBP) present a huge 52 
increase during resistance exercise that is proportional to the active muscle mass 53 
required to perform the exercise[10]. As patients with PD can present with autonomic 54 
dysfunction, atypical cardiovascular responses may be expected when they perform 55 
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these kind of exercises, and these responses might be more evident when the stimulus is 56 
greater, such as during exercise involving a large muscle mass. In the limited amount of 57 
previous studies on cardiovascular responses to aerobic exercise (leg cycling), preserved 58 
[11] or blunted[12] responses have been reported in PD patients with either presumably 59 
intact[13], impaired[14] or unreported autonomic function[12].Thus, the objective of 60 
this study was to compare,  patients with PD and age-matched healthy controls, HR and 61 
SBP responses during resistance exercise requiring different amounts of active muscle 62 
mass. 63 
 64 
METHODS 65 
Experimental Design 66 
The hypothesis of this study was that patients with PD present abnormal 67 
cardiovascular responses during resistance exercise, and that the abnormality of these 68 
responses are greater during exercise that recruits a larger muscle mass. To test this 69 
hypothesis, patients with PD and healthy controls underwent an experimental session, in 70 
which they performed, in a random order, two resistance exercises (i.e. unilateral and 71 
bilateral knee extension exercises) with an interval of, at least, 10 minutes between 72 
them. During each exercise, they performed 2 sets of 10-12RM with a 2 min interval, 73 
and SBP and HR were continuously measured. 74 
 75 
Subjects 76 
 Thirteen patients with PD and 13 control subjects were studied. Groups were 77 
similar regarding age, gender distribution, body mass index (BMI), BP, HR and leg-78 
extension 10-12 RM load (all P>.05, Table 1).Patients with PD were recruited from the 79 
Brazilian Parkinson Association and had PD for 8.8±1.2 years. To participate in the 80 
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study, they had to: i) present a diagnosis of idiopathic Parkinson’s disease as diagnosed 81 
by an experienced specialist in movement disorders, following the UK Brain Bank 82 
criteria[15], and ii) be at stages 2 to 3 of the modified Hoehn and Yahr Scale [16]. In 83 
addition, subjects without any known neurological disease matched to the PD patients 84 
for age, gender, body mass index (BMI), resting BP and strength were used as a control 85 
group. The exclusion criteria for both groups were: i) presence of arterial hypertension; 86 
ii) presence of cardiovascular disease; iii) presence of orthopedic disease that could 87 
limit exercise performance; iv) use of medications that could directly affect 88 
cardiovascular system, except for the medications used for the treatment of PD; v) 89 
participate on in any regular exercise program, except for physiotherapy for the 90 
treatment of PD; and v) any previous experience with resistance training in the last 6 91 
months. All volunteers signed an informed written consent form approved by the Ethics 92 
Committee of the School of Physical Education and Sport, University of São Paulo 93 
(2011/42), and the study was registered at the Brazilian Clinical Trials (U111-1129-94 
0762). 95 
 96 
Procedures and Instrumentation 97 
 As a preliminary evaluation, all patients with PD were examined by a 98 
specialized physician to confirm the diagnosis of PD and the Hoehn and Yahr stage. In 99 
addition, patients with PD and control subjects were interviewed for the presence of 100 
other diseases, physical activity level and medication use. Auscultatory seated resting 101 
BP was measured in triplicate on two occasions following the hypertension guidelines 102 
for both groups[17]. Subjects were excluded if mean resting systolic/diastolic BP were 103 
> 140/90 mmHg, or if the interview revealed the presence of any of the exclusion 104 
criterion. 105 
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 Volunteers (patients with PD and control subjects) who fulfilled the study 106 
criteria performed a familiarization session to learn the technique of the 107 
unilateral(conducted with the more affected leg of the patients with PD and with the 108 
non-dominant leg in the control subjects) and bilateral knee-extension exercises 109 
(Nakagym, NK-5060 São Paulo, Brazil), and to allow the estimation of the workload 110 
corresponding to 10 to 12 RM for both exercises. This session was conducted with the 111 
PD patients during the on-state of medication (i.e. they took the medication 20 minutes 112 
prior to the beginning of the session). The session initiated with a 5-min warm-upon a 113 
cycle ergometer (Lifefitness, 5500,São Paulo, Brazil)with zero watts and was followed 114 
by the unilateral and bilateral knee extension exercises (random order). The work load 115 
corresponding to 10-12 RM on each exercise (unilateral and bilateral) was estimated by 116 
gradually increasing the workload on each set. At the end of each set, rating of 117 
perceived exertion was assessed using the OMNI-REP scale[18]. If the rate was lower 118 
than 8-10, the exercise workload was increased and an additional set was performed. A 119 
2 min interval was allowed between the sets and 10min interval between the exercises. 120 
At least 7 days after the familiarization session, subjects reported to the 121 
laboratory for the experimental session. They were instructed to refrain from exercise 122 
for the previous 48 hours, to avoid the ingestion of stimulants (e.g., coffee, tea, 123 
caffeinated drinks and soda) in the previous 12 hours, and to have a light meal 2 hours 124 
before the experimental session. In addition, patients with PD were instructed to take 125 
their PD medications 20 minutes before the beginning of the protocol (i.e. on-state of 126 
medication). The session was conducted in a temperature-controlled laboratory (21 to 127 
23
o
C). 128 
During the experimental session (Figure 1), all volunteers warmed-up for 5 min 129 
on a cycle ergometer (Lifefitness, 5500, São Paulo, Brazil) with a comfortable 130 
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workload, and then, performed a specific warm-up in the unilateral and bilateral knee-131 
extension exercises (2 sets of 5 repetitions on each exercise: first set with a comfortable 132 
workload, a 2-min rest interval, and second set with the estimated workload 133 
corresponding to 10-12 RM). After 10 min, the experimental protocol was initiated. The 134 
volunteers performed the unilateral or bilateral knee-extension exercises in a counter 135 
balanced random order and for 2 sets of 10-12 RM with a 2-min interval between the 136 
sets and a 10-min rest between the exercises. For each exercise, BP and HR were 137 
recorded at rest (for the 3 min before the exercise) and during the exercise protocol 138 
(during both sets and during the interval between sets). 139 
 BP was measured beat-by-beat by photoplethysmography using the Finometer 140 
(Finapress Measurement System, Finometer, Arnhem, Netherlands) on the left arm and 141 
HR was monitored by a 3-lead electrocardiographic system (Cardio Perfect, model ST 142 
2001, Netherlands). Both signals were digitalized and recorded online using a data 143 
acquisition system (Windaq, DI–720, Ohio, USA) with a sampling frequency of 500 144 
Hz/channel. 145 
 146 
Statistical Analyses 147 
 A previous study[19] showed that only SBP responses during resistance exercise 148 
corresponded to intra-arterial BP responses when assessed by the 149 
photoplethysmographic method. Thus, in the present study, diastolic BP responses were 150 
not analyzed. Pre-exercise SBP and HR values were assessed as the mean of the 2 151 
minutes before the beginning of exercise. Exercise SBP and HR values were established 152 
as the highest values achieved during each set (S1 and S2) at samples of 40-48 seconds 153 
and the lowest value obtained during the 2 minutes rest interval between sets (INT). The 154 
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changes in the responses () were calculated by subtracting the values obtained during 155 
exercise from pre-exercise. 156 
 The normality of data were confirmed by Shapiro–Wilk tests (IBM SPSS 157 
Statistics version 20). Chi-square and T tests were used for comparing descriptive data 158 
between groups (patients with PD and control subjects). SBP and HR responses to each 159 
exercise (i.e. bilateral and unilateral) were firstly analyzed using a two-way ANOVA, 160 
considering group (patients with PD and control subjects) as a between main factor and 161 
exercise phase (Pre, S1, INT and S2) as a within main factor. Afterwards, the changes 162 
() to both exercise in both groups were compared using a three-way ANOVA, with 163 
group (patients with PD and control subjects) as a between main factor, and exercise 164 
(unilateral or bilateral) and set (S1 and S2) as within main factors. Newman Keuls post-165 
hoc tests were applied when necessary (Statistica version 5.0). Significance level was 166 
defined as P ≤ .05. Data are presented as mean ± SE. 167 
 168 
RESULTS 169 
Thirteen volunteers initiated the protocol with the unilateral exercise; while the 170 
other 13 performed bilateral exercise first. Pre-exercise SBP and HR were not different 171 
between unilateral and bilateral exercises (11917 vs. 11617 mmHg, P=.16 and 778 172 
vs. 768 bpm, P=.27). 173 
During the unilateral knee extension exercise, SBP and HR analyses presented 174 
significant interactions between group and exercise phase in ANOVA (P<.001for both). 175 
Newman Keuls post-hoc comparisons showed that SBP and HR increased significantly 176 
during both sets and returned to pre-exercise levels during the rest interval in both 177 
groups, except for SBP that decreased below pre-exercise during the rest interval in the 178 
PD group (Figure 2A and 2B). In addition, SBP was significantly higher in the control 179 
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group compared to PD throughout the protocol (S1: 188±6 vs. 156±5, INT: 116±5 vs. 180 
100±4, and S2: 195±6 vs. 159±6 mmHg, respectively), while HR was higher in the 181 
control group in both sets (S1: 104±4 vs. 95±3, and S2:105±4 vs. 95±3 bpm, 182 
respectively), but was similar between the groups in the rest interval. 183 
During the bilateral knee extension exercise, SBP and HR analyses presented 184 
significant interactions between group and exercise phase in ANOVA (P<.001 for both). 185 
Newman Keuls post-hoc comparisons showed that SBP and HR increased significantly 186 
during both sets and returned to pre-exercise values during the rest interval in both 187 
groups (Figure 2C and 2D). In addition, SBP was significantly higher in the control 188 
group compared to PD throughout the protocol (S1: 203±9 vs. 158±4, INT: 118±6 vs. 189 
102±4, and S2: 203±8 vs 164±4mmHg, respectively). HR was also significantly higher 190 
in the control group during both sets (S1: 107±5 vs. 97±3and S2: 108±6 vs. 96±3 bpm, 191 
respectively), but was similar between the groups during the rest interval. 192 
 There were no significant interactions for SBP and HR as assessed by the 3-193 
way ANOVAs. However, for SBP, there were significant main effects for group 194 
(P=.003), exercise (P=.002), and set (P=.04) (Figure 3, panel A).Thus, independent of 195 
group and set, SBP increase was greater during bilateral than unilateral exercise (mean 196 
values: +63±4 vs +54±3 mmHg).Furthermore, independent of group and exercise type, 197 
SBP increase was higher in S2 than S1 (+61±4 vs. +56±4 mmHg), and independent of 198 
exercise type and set, the SBP increase was greater in the control group compared to 199 
patients with PD(mean values: +73±4 vs +45±2 mmHg). For HR, only the main factor 200 
of group presented a significant main effect (P=.007) (Figure 3, panel B), showing that 201 
independent of exercise type and set, the HR increase was lower in PD than the control 202 
group (mean values: +18±1 vs. +31±2 bpm). 203 
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 204 
DISCUSSION 205 
 206 
The main finding of this study was that patients with PD presented blunted SBP 207 
and HR increases during unilateral and bilateral knee extension exercise in comparison 208 
with control subjects without PD. To the best of our knowledge, this is the first study to 209 
describe the cardiovascular responses to resistance exercise in patients with PD. As 210 
resistance training has been widely recommended for individuals with PD to improve 211 
motor symptoms and functionality[20,21], the understanding of cardiovascular 212 
responses to resistance exercise is important. Due to autonomic and cardiovascular 213 
abnormalities in PD[2,22], the main hypothesis of this study was that patients with PD 214 
would present altered responses during resistance exercise. The findings of the present 215 
study support this hypothesis, as patients with PD presented blunted cardiovascular 216 
responses during resistance exercise, regardless of the size of the active muscle mass.  217 
Accordingly, peak values of absolute as well as increases in SBP and HR during 218 
exercise were lower in the PD relative to the control group. These findings are in 219 
agreement with other studies that have also reported blunted cardiovascular responses in 220 
patients with PD during aerobic exercise[12,23]. 221 
The mechanisms responsible for the lower responses to resistance exercise in PD 222 
were not assessed in the present study, and these mechanisms remain to be elucidated. 223 
BP and HR increases during resistance exercise have been attributed to the stimulation 224 
of central and peripheral regulatory mechanisms (central command, mechanoreflex and 225 
metaboreflex) that deactivate cardiac vagal activity and stimulate cardiac and peripheral 226 
sympathetic activities[24,25]. Thus, it is possible that the autonomic dysfunction 227 
typically present in PD, which is mainly characterized by sympathetic 228 
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dysfunction[9],could be responsible for the blunted HR and SBP increases observed in 229 
the present study. Accordingly, Haensch et al.[9] showed the presence of cardiovascular 230 
dysfunction in PD with loss of sympathetic innervation to the heart and an associated 231 
reduction in sympathetic release of norepinephrine in response to a stimulus[14]. As 232 
norepinephrine increases HR, peripheral vascular resistance and BP[26], it is reasonable 233 
to suggest that sympathetic activation during resistance exercise may be blunted in 234 
patients with PD, mitigating HR and BP increases. Similar findings have been reported 235 
in other similar neurodegenerative disorders with autonomic dysfunction (e.g., Multiple 236 
System Atrophy, Pure Autonomic Failure)[2,27]. 237 
The present data do not support the hypothesis that activating a larger muscle 238 
mass during resistance exercise results in a greater blunting of SBP and HR increases in 239 
PD. This response suggests that the consequences of blunted sympathetic activation is 240 
likely to occur even with the recruitment of a small muscle mass. In fact, even with a 241 
weak sympathetic stimulus, such as a head-up tilt test, many patients with PD show 242 
large decreases in BP, reflecting the blunted capacity to increase sympathetic 243 
activity[28]. 244 
It is interesting to observe that the SBP increase during resistance exercise was 245 
higher during the larger relative to the smaller muscle mass, while HR increased 246 
similarly in both exercise types. This result is similar to others[10], but needs to be 247 
explained. The increment in BP during resistance exercise is partially promoted by the 248 
mechanical obstruction of blood flow around the contracting muscle, which is doubled 249 
in bilateral exercise[10]. In addition, the contraction of a greater muscle mass enhances 250 
mechanoreflex and metaboreflex stimuli[10,29]. All these mechanisms may explain the 251 
greater increase in SBP during the bilateral exercise. On the other hand, the increment in 252 
HR during resistance exercise is mainly attributed to the central command reduction in 253 
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vagal activity[24,25], which may not differ so much between bilateral and unilateral 254 
resistance exercise. In addition, the HR increase may be partially blunted by baroreflex 255 
stimulation due to the increase in BP during exercise, and this blunted response might 256 
be greater with a greater muscle mass since the BP increase was higher with bilateral 257 
resistance exercise. The balance among these mechanisms might explain the absence of 258 
a greater increase in HR during bilateral compared to than unilateral exercise. 259 
A similar explanation might be responsible for the fact that the SBP, but not the 260 
HR, increase was higher in the second than in the first set of resistance exercise. During 261 
resistance exercise, central command, mechano and metaboreflexes are progressively 262 
activated throughout the repetitions within each set due to the increase in fatigue and 263 
metabolite accumulation[24,25], which explains the increase in SBP from S1 to S2. 264 
Once more, the higher increase in SBP might produce a greater stimulus for baroreflex 265 
activation, therefore blunting an assumed greater increase in HR in the second set. 266 
 Resistance training is recommended for patients with PD for improving 267 
muscular and motor functions[21]. In addition, in a previous study, we reported that 268 
resistance training produces cardiac autonomic benefits in this population[7]. However, 269 
as a huge and sharp increase of BP is usually observed during the execution of 270 
resistance exercise [10], there is some concern among physicians regarding the 271 
possibility of occurrence of acute cardiovascular events (e.g. a stroke or sudden death) 272 
during the execution of this type of exercise in clinical populations that have high 273 
cardiovascular risk [30], including patients with PD. Thus, the main clinical implication 274 
of the present study is the demystification of the possible acute cardiovascular risk of 275 
executing resistance training in patients with PD.As the present results showed that BP 276 
and HR presented smaller increases during resistance exercise execution in patients with 277 
PD than in control subjects, and no adverse effect has been observed during the 278 
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experimental protocol (e.g., dizziness, fainting or marked falls in BP or HR), the present 279 
study supports that resistance exercise is safe and well tolerated for patients with PD 280 
from a cardiovascular point of view; supporting its recommendation for this population. 281 
However, it is also important to note that despite the lower BP and HR increases during 282 
resistance exercise, patients with PD still have greater increases in BP and HR when 283 
larger muscle masses were employed and when exercise is performed with more sets; 284 
which should be considered when designing a resistance training protocol for this 285 
population. 286 
This study presents some limitations. As the study design required subjects to be 287 
able to perform resistance exercise without external help, only patients in stages 2 and 3 288 
of the modified Hoehr and Yahr scale were able to participate. In addition, as the aim of 289 
the present study was to investigate cardiovascular responses in PD without the 290 
influence of other diseases, the participants did not present with hypertension or any 291 
other cardiovascular disease. However, it is usual to detect cardiovascular disease in 292 
patients with PD in different stages of the disease. These patients might have greater 293 
dysautonomia and respond differently to resistance exercise. Future studies are required 294 
to understand cardiovascular responses to resistance exercise in patients with Parkinson 295 
and cardiovascular disease and varying levels of dysautonomia. Regarding usage of PD 296 
medication, patients were taking different drugs and doses, which did not allow the 297 
determination of the effects of each PD medication but it does increase the external 298 
validity of the present results as patients with PD regularly take different 299 
pharmacotherapies. Considering the exercise protocol, this study employed only one 300 
dynamic resistance exercise performed with one or two legs; and used two sets of 10-12 301 
repetitions. The magnitude of cardiovascular responses might be different with different 302 
exercises, volumes and intensities. However, it is unlikely that modifications in the 303 
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exercise protocol would eliminate the differences in cardiovascular responses observed 304 
between subjects with and without PD. 305 
 306 
Conclusions 307 
 Patients with PD present blunted SBP and HR increases during resistance 308 
exercise in comparison with healthy subjects, showing that this type of exercise is safe 309 
and well tolerated for patients with PD from a cardiovascular point of view and 310 
supporting its recommendation for this population. 311 
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Figure legends 432 
Figure 1: Experimental Protocol. HR = Heart Rate, SBP = Systolic Blood Pressure, RM 433 
= maximal repetition 434 
435 
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Figure 2: Systolic blood pressure (SBP, panels A and C) and heart rate (HR, panels B 436 
and D) measured before (pre) and during the first set (S1), the interval (INT) and the 437 
second set (S2) of the unilateral (panels A and B) and the bilateral (panels C and D) 438 
knee extension exercise in Parkinson disease patients (PD, dotted lines with circles) and 439 
control subjects (CONTROL, solid line with triangles). Data are shown as mean ± SE. † 440 
significantly different from PD (P<.05). ‡ significantly different from pre (P<.05). 441 
 442 
443 
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Figure 3: Systolic blood pressure (SBP, panel A) and heart rate (HR, panel B) 444 
increases during the first (S1) and second (S2) sets of the unilateral (UNI) and bilateral 445 
(BI) knee extension exercises in patients with Parkinson disease (PD) and control 446 
subjects (CONTROL). Results of group, exercise and set main effects.Data is presented 447 
as mean ± SE. [] Main effect of ANOVA.  † Different from PD group. ‡ Different from 448 
S1. § Different from unilateral 449 
 450 
451 
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Table 1. Characteristics of the patients with Parkinson disease (PD) and the control 452 
subjects. 453 
BMI – Body mass index, SBP – systolic blood pressure, DBP– diastolic blood pressure, 454 
HR- heart rate, RM – repetition maximum, H&Y – modified Hoehn-Yahr stage. Data = 455 
mean ± SE.  456 
 457 
Table 1. Characteristics of the patients with Parkinson disease (PD) and the control 
subjects. 
 PD CONTROL P 
N 13 13  
Age (years) 62.7±1.3 66.2±2.0 .16 
Gender (F/M) 9/4 7/6 .42 
BMI (kg/m
2
) 25.9 ±1.1 25.6±1.0 .86 
SBP (mmHg) 119.0±3.1 122.7±1.8 .33 
DBP (mmHg) 79.8±1.8 81.7±1.3 .41 
HR (bpm) 69.7±1.4 69.4±2.3 .89 
Workload 10-12 RM BI (kg) 36.1±3.5 36.9±2.9 .86 
Workload 10-12 RM UNI (kg) 18.8±1.7 20.7±1.4 .40 
H & Y 2/2.5/3 (n) 4/6/3 --------- ------------ 
BMI – Body mass index, SBP – systolic blood pressure, DBP– diastolic blood pressure, 
HR- heart rate, RM – repetition maximum, H&Y – modified Hoehn-Yahr stage. Data = 
mean ± SE. 
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